The superior  Point of Care Diagnostics Market report acts as a thorough synopsis on the study, analysis and estimation of the market and how it is affecting the Point of Care Diagnostics Market industry. The report gives current as well as upcoming technical and financial details of the industry to 2030. It presents with a telescopic view of the competitive landscape to the client so that they can map the strategies accordingly. e.g. strategic planning supports businesses improve and enhance their products which customers will desire to buy. The research study carried out in the worldwide Point of Care Diagnostics Market report covers the local, regional as well as global market.

Point of Care Diagnostics Market analysis document is a decisive source of information about the industry, important facts and figures, expert opinions, and the newest developments across the globe. This market report works as an outstanding resource that provides recent as well as upcoming technical and financial details of the industry to 2030. As it’s a fact that competitive analysis is the major aspect of any market research report, the report covers many points including strategic profiling of key players in the market, analyse core competencies of key players, and draw a competitive landscape for the market.

Point-of-care testing diagnostics have numerous advantages, allowing patients to be diagnosed in a variety of settings, including the doctor's office, an ambulance, the home, the field, or the hospital. The outcomes of care are timely and provide the patient with prompt treatment. Chronic diseases, such as diabetes, rheumatism, and cancer, are becoming more common around the world for a variety of reasons, including an increase in the geriatric population, sedentary lifestyles, unhealthy eating habits, and environmental factors. Chronic diseases, for example, kill more than 38 million people worldwide each year. Cardiovascular diseases cause the most chronic disease deaths each year, killing 17.5 million people, followed by cancer (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).                          

Data Bridge Market Research analyzes that the global point of care diagnostics market which was USD 40,280.13 million in 2023, is expected to reach USD 71,424.23 million by 2031, and is expected to undergo a CAGR of 9.1% during the forecast period of 2024 to 2031. “Lateral flow assays” dominate the platform segment of the market due to rising demand for point of care diagnostics. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Explore Further Details about This Research Point of Care Diagnostics Market Report https://www.databridgemarketresearch.com/reports/global-point-of-care-diagnostics-market

REPORT METRIC

DETAILS

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), Prescription (Prescription-Based Testing, OTC Testing), End-User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Product (Glucose, Cardio Metabolic, Infectious Disease, Influenza, HIV, Hepatitis C, Sexually Transmitted Disease (STD), Healthcare-Associated Infection (HAI), Respiratory Infection, Tropical Disease, Other Infectious Disease, Coagulation, PT/INR Activated Clotting Time (ACT/APTT), Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Other POC Products)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America

Market Players Covered

Abbott(U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Chembio Diagnostics (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), bioMérieux S.A. (France)

Market Opportunities
  • Advancements in personalized medicine
  • Integration of AI and big data analytics
  • Research and development
 

Market Definition

Point-of-care diagnostics (POC diagnostics) refer to medical diagnostic testing performed outside of a traditional laboratory setting, typically at or near the location where the patient is receiving care. The purpose of point-of-care diagnostics is to provide rapid and convenient access to diagnostic information, allowing healthcare professionals to make timely decisions about patient management.

Global Point of Care Diagnostics Market Dynamics

Drivers

  • Rising Demand for Instantaneous Results

The healthcare landscape has seen an increasing preference for rapid and immediate test results. Point-of-care diagnostics fulfill this need by offering quick outcomes, reducing patient wait times, and enabling immediate treatment decisions. This demand is particularly crucial in emergency rooms, ambulances, and rural or remote healthcare settings where prompt diagnoses are critical for patient care. In addition, the escalating demand for quick COVID-19 testing during the pandemic highlighted the significance of point-of-care diagnostics. These tests became instrumental in identifying cases swiftly, aiding in containment efforts and preventing further transmission.

  • Technological Advancements in Diagnostics

Technological innovations have significantly transformed point-of-care diagnostics. Miniaturization, advanced biosensors, and lab-on-a-chip technologies have enhanced the accuracy, sensitivity, and specificity of these devices. This evolution allows for a broader range of diagnostic tests, making them more accessible and user-friendly across various healthcare settings. Furthermore, the integration of point-of-care devices with digital health solutions and smartphone applications has augmented their utility, enabling real-time data sharing, remote monitoring, and improved patient engagement.

  • Increasing Prevalence of Infectious Diseases

The prevalence of infectious diseases globally, including HIV, malaria, tuberculosis, and more recently, the COVID-19 pandemic, has driven the need for rapid and decentralized testing. Point-of-care diagnostics play a pivotal role in detecting these infections swiftly, aiding in early intervention, treatment initiation, and prevention of further spread. The heightened focus on pandemic preparedness and the need for quick and accurate diagnostics during public health emergencies has further accentuated the demand for point-of-care testing platforms.

Key Benefits of the Report:

  • This study presents the analytical depiction of the global Point of Care Diagnostics Market ndustry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Point of Care Diagnostics Market share.
  • The current market is quantitatively analyzed from 2022 to 2029 to highlight the  Point of Care Diagnostics Market growth scenario.
  • Porter's five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Point of Care Diagnostics Market analysis based on competitive intensity and how the competition will take shape in coming years.

Why choose Data Bridge Market Research?

  • Modern technologies, such as artificial intelligence, to provide updated industry growth.
  • DBMR team provides clients with the top notch Point of Care Diagnostics Market research report.
  • Interaction with research scientists and development heads to understand the nature of the Point of Care Diagnostics Market more precisely.
  • 24/7 availability of services.
  • Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective with Forecast period.

DBMR team uses very fair means to gather information that is scrutinized at every stage while structuring an influential Point of Care Diagnostics Market size

Browse Related Reports:  

Pharmaceutical Packaging Equipment Market  Size, Share, Trends, Growth, Forecast

Trauma Fixation Market  Size Outlook and Beyond

Antibiotic Residue Test Kits Market  Report | Global Forecast

Neurophotonics Market  Demand,Size ,Share, Industry

Fluid Management Equipment Market  Size, Analysis and Forecast

Aortic Stent Grafts Market  Size, Share, Trends & Forecast

Neonatal Phototherapy Market  Size And Share Analysis Report,

Wearable Artificial Kidney Market  by Size, Share, Forecast, & Trends

Embolization Particle Market  Size Report- Industry Growth Analysis

Healthcare Original Equipment Manufacturer (OEM) Market  Size, Industry Share Forecast

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com